Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Apyx Medical (APYX) Short term Debt (2016 - 2023)

Apyx Medical (APYX) has disclosed Short term Debt for 12 consecutive years, with $8.9 million as the latest value for Q2 2023.

For the quarter ending Q2 2023, Short term Debt changed N/A year-over-year to $8.9 million, compared with a TTM value of $8.9 million through Jun 2023, changed N/A, and an annual FY2019 reading of $140000.0, changed N/A over the prior year.
Short term Debt was $8.9 million for Q2 2023 at Apyx Medical, up from $8.8 million in the prior quarter.
Across five years, Short term Debt topped out at $8.9 million in Q2 2023 and bottomed at $140000.0 in Q4 2019.
Average Short term Debt over 3 years is $3.0 million, with a median of $140000.0 recorded in 2019.